Academic Journals Database
Disseminating quality controlled scientific knowledge

SYNTHESIS, MOLECULAR DOCKING STUDIES AND BIOLOGICAL EVALUATION OF 5-[4-(SUBSTITUTED) BENZYLIDENE OR BENZYL] THIAZOLIDINE-2, 4-DIONE WITH THEIR ORAL HYPOGLYCEMIC ACTIVITY

ADD TO MY LIST
 
Author(s): Akhiles Roy | Mahesh Ramdas Dumbare | Shilpa Sudhakar Harak | Momin Zarina Mohammad Najeeb | Rohini Dattatray Deshmukh

Journal: International Research Journal of Pharmacy
ISSN 2230-8407

Volume: 4;
Issue: 8;
Start page: 151;
Date: 2013;
VIEW PDF   PDF DOWNLOAD PDF   Download PDF Original page

Keywords: Thiazolidinediones (TZD’s) | Hyperglycemia | Docking | oral hypoglycemic activity.

ABSTRACT
A new series of 5-[4-(substituted) benzylidene or benzyl] thiazolidine-2, 4-dione (TZDs) have been synthesized using economical synthetic routes. The aim of the synthesis based on modification of linker region and effector region of rosiglitazone. Among these newly synthesized compounds, based on their docking results, some compounds were selected for study of oral hypoglycemic activity on fructose induced hyperglycemia in Wistar rats. The results of selected compounds shows that, 5-[4-(2-amino-5-ethoxypyridine) sulphonyl benzylidene] thiazolidine-2, 4-dione and 5-[4-(2-amino-5-ethoxypyridine) ethoxy benzyl] thiazolidine-2, 4-dione have appreciable blood glucose-lowering effect compared to that of the reference drug, pioglitazone. Out of these two compounds, 5-[4-(2-amino-5-ethoxypyridine)ethoxy benzyl] thiazolidine-2, 4-dione shows better hydrogen bond interaction with amino acid residues of peroxisome proliferator activated receptor-gamma (PPARγ) and also shows better oral hypoglycemic activity in this series.
Save time & money - Smart Internet Solutions      Why do you need a reservation system?